Header Logo

Connection

COYA TAPIA to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications COYA TAPIA has written about Dose-Response Relationship, Drug.
COYA TAPIA
Connection Strength
0.026
Dose-Response Relationship, Drug
  1. First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021 03 04; 23(1):29.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.